Zimmer Biomet Holdings, Inc.
ZBH
$82.72
-$0.65-0.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.30% | 10.90% | 9.71% | 6.97% | 1.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.30% | 10.90% | 9.71% | 6.97% | 1.05% |
| Cost of Revenue | 2.62% | 38.30% | 3.84% | 6.70% | 7.32% |
| Gross Profit | 12.01% | 0.02% | 12.17% | 7.07% | -1.28% |
| SG&A Expenses | 11.80% | 19.27% | 14.78% | 10.09% | 3.06% |
| Depreciation & Amortization | 7.35% | 12.75% | 19.10% | 11.53% | 6.26% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.86% | 25.00% | 10.47% | 8.54% | 4.78% |
| Operating Income | 20.54% | -34.56% | 6.14% | 0.92% | -13.17% |
| Income Before Tax | 31.51% | -66.14% | 21.18% | -25.68% | 6.51% |
| Income Tax Expenses | 35.48% | -181.60% | 353.97% | 20.47% | 9.93% |
| Earnings from Continuing Operations | 30.50% | -42.63% | -7.26% | -36.90% | 5.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 66.67% | 314.29% | -50.00% | -100.00% | -50.00% |
| Net Income | 30.82% | -41.84% | -7.31% | -37.07% | 5.57% |
| EBIT | 20.54% | -34.56% | 6.14% | 0.92% | -13.17% |
| EBITDA | 14.38% | -19.54% | 9.17% | 5.01% | -5.69% |
| EPS Basic | 33.44% | -41.28% | -5.34% | -34.59% | 8.90% |
| Normalized Basic EPS | 25.23% | -36.04% | 1.50% | -3.44% | -16.07% |
| EPS Diluted | 34.07% | -40.77% | -5.69% | -34.75% | 8.33% |
| Normalized Diluted EPS | 25.22% | -36.07% | 1.48% | -3.30% | -15.99% |
| Average Basic Shares Outstanding | -1.96% | -0.95% | -2.08% | -3.79% | -3.07% |
| Average Diluted Shares Outstanding | -1.95% | -0.90% | -2.07% | -3.92% | -3.15% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.25% | 0.70% | 0.04% | 0.53% | -0.08% |